SB 200-FN - AS INTRODUCED

2015 SESSION

15-0623

01/08

SENATE BILL 200-FN

AN ACT relative to newborn screening for Krabbe Leukodystrophy.

SPONSORS: Sen. Cataldo, Dist 6; Sen. Carson, Dist 14; Sen. Stiles, Dist 24; Rep. Itse, Rock 10

COMMITTEE: Health and Human Services

ANALYSIS

This bill requires newborns to be screened for Krabbe Leukodystrophy.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

15-0623

01/08

STATE OF NEW HAMPSHIRE

In the Year of Our Lord Two Thousand Fifteen

AN ACT relative to newborn screening for Krabbe Leukodystrophy.

Be it Enacted by the Senate and House of Representatives in General Court convened:

1 Newborn Screening; Globoid Cell Leukodystrophy (Krabbe). Amend the introductory paragraph of RSA 132:10-a, I to read as follows:

I. The physician, hospital, nurse midwife, midwife, or other health care provider attending a newborn child shall test a newborn child for metabolic disorders. Such tests shall include, but not be limited to, phenylketonuria, galactosemia, homocystinuria, maple syrup urine disease, [and] hypothyroidism, and globoid cell leukodystrophy (krabbe). Additional disorders shall be added to the newborn screening panel based upon, but not limited to, the following considerations:

2 Effective Date. This act shall take effect 60 days after its passage.

LBAO

15-0623

01/12/15

SB 200-FN - FISCAL NOTE

AN ACT relative to newborn screening for Krabbe Leukodystrophy.

FISCAL IMPACT:

METHODOLOGY: